US20150189896A1 - Methods using patatin - Google Patents

Methods using patatin Download PDF

Info

Publication number
US20150189896A1
US20150189896A1 US14/411,536 US201314411536A US2015189896A1 US 20150189896 A1 US20150189896 A1 US 20150189896A1 US 201314411536 A US201314411536 A US 201314411536A US 2015189896 A1 US2015189896 A1 US 2015189896A1
Authority
US
United States
Prior art keywords
patatin
cheese
milk
fatty acids
curd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/411,536
Other languages
English (en)
Inventor
Robin Eric Jacobus Spelbrink
Marco Luigi Federico Giuseppin
Maarten Robert Egmond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cooperative Avebe UA
Original Assignee
Cooperative Avebe UA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cooperative Avebe UA filed Critical Cooperative Avebe UA
Assigned to COÖPERATIE AVEBE U.A. reassignment COÖPERATIE AVEBE U.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GIUSEPPIN, MARCO LUIGI FEDERICO, SPELBRINK, ROBIN ERIC JACOBUS, EGMOND, MAARTEN ROBERT
Publication of US20150189896A1 publication Critical patent/US20150189896A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00Cheese; Cheese preparations; Making thereof
    • A23C19/06Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/09Other cheese preparations; Mixtures of cheese with other foodstuffs
    • A23C19/0921Addition, to cheese or curd, of minerals, including organic salts thereof, trace elements, amino acids, peptides, protein hydrolysates, nucleic acids, yeast extracts or autolysate, vitamins or derivatives of these compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00Cheese; Cheese preparations; Making thereof
    • A23C19/02Making cheese curd
    • A23C19/04Making cheese curd characterised by the use of specific enzymes of vegetable or animal origin
    • A23C19/043Enzymes other than proteolytic enzymes or milk clotting enzymes, e.g. lipase, lysosyme
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00Cheese; Cheese preparations; Making thereof
    • A23C19/02Making cheese curd
    • A23C19/05Treating milk before coagulation; Separating whey from curd
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00Cheese; Cheese preparations; Making thereof
    • A23C19/06Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/063Addition of, or treatment with, enzymes or cell-free extracts of microorganisms
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B3/00Refining fats or fatty oils
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/02Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with glycerol
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • C12P7/649Biodiesel, i.e. fatty acid alkyl esters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003Triacylglycerol lipase (3.1.1.3)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Definitions

  • esters can be hydrolysed chemically using either strong bases or acids, such procedures are crude and non-specific, resulting in loss of yield, undesired side products and waste.
  • Enzymatic hydrolysis is generally more specific, avoiding at least part of these problems.
  • Lipases are surface enzymes that are often selective for the hydrolysis of specific lipids in terms of fatty acid chain length or fatty acid chain position. This specificity determines how appropriate a specific lipase is for any given application.
  • lipases are common in industry. Examples include racemic drug resolution, fat and lipid modification, flavour synthesis and the production of pharma- and nutraceuticals.
  • the vast majority of lipases that are presently in use are obtained using fungal or bacterial fermentation systems, although animal-derived lipases see some use as well. Plant-derived lipases are relatively rare for industrial applications.
  • lipases are obtained by bacterial fermentation and require cumbersome downstream processing. Such lipases tend to be of low purity on both a total- and protein-basis and therefore contain high amounts of carbohydrates, salts and possible undesired side-activities. Furthermore, commercial lipase preparations generally contain a broad variety of non-protein material, salts and non-lipase enzymes (Bjurlin et al 2001 JAOCS 78-2 p 153-160).
  • lipases to produce flavour in a food product such as cheese is quite common, and many different lipase preparations have been reported.
  • the digestive enzymes from calves or pigs called rennet
  • rennet would be added to cheese, because rennet is able to induce coagulation of milk, and because rennet induces the production of free fatty acids, which confer flavour to cheese.
  • This process involves expensive enzyme isolation requiring dead calves or pigs, which is cumbersome and unsuitable for vegetarians. Also, it introduces the possibility of transfer of diseases.
  • cheese is made by coagulation of milk, for instance by the addition of rennet and/or acid.
  • milk separates into curd and whey.
  • Whey a watery solution of milk proteins, is discarded, while the curd is collected and gently pressed to remove some of the remaining water.
  • the curd obtained contains approximately 30% water, and should be considered a colloidal dispersion of milk fat, proteins and water.
  • Suitable enzymes are added, either to the milk or to the curd (e.g. in the form of rennet). For most cheeses, the curd is subsequently allowed to ripen.
  • microbial lipases are preferred for cheese-making, and in general use is made of genetically modified bacteria to obtain one specific type of lipase.
  • Such lipases require complicated and expensive isolation methods and may lead to rancidity in the final product because the reaction often has to be continued for too long time.
  • a plant-derived lipase enzyme can be obtained from potato.
  • Potato proteins can be divided into three categories: (i) the patatin family, highly homologous acidic 43 kDa glycoproteins (the high-molecular weight fraction, “HMW”, making up 40-50 wt. % of the potato proteins), (ii) basic 5-25 kDa protease inhibitors (“PI”, 30-40 wt. % of the potato proteins) and (iii) other proteins mostly high molecular weight proteins (10-20 wt. % of the potato proteins).
  • the patatin family is known to have some lipase activity, and can be obtained via a single-step chromatographic process followed by concentration and drying. A highly convenient process for the isolation of among others patatin with high purity is described in application WO2008/069650.
  • patatin In practice, potato proteins, including lipase, have been mainly used as feedstock for animals because of a lack of practical commercial use. Generally, practical use of patatin has been considered limited because patatin is inactive towards triglycerides (see for instance Hirschberg et al, Eur. J. Biochem 2001, 268, 5037, Galliard et al., Biochem. J. 1971, 121, 379 or Andrews et al, Biochem J. 1988, 252, 199), even though it has esterase activity on among others phospholipids and monoglycerides.
  • patatin provides a means of using patatin in an aqueous phase for the hydrolysis of specific types of lipids. It has been found that patatin is capable of hydrolysing a C 4 -C 8 fatty acid from a triglyceride. However, it will not, or essentially not, hydrolyse glycerol fatty acid esters of longer chain lengths. Thus, patatin displays a surprising selectivity for short- and medium chain fatty acids, especially in aqueous environment. It has been found that this selectivity allows for high practical value in the making of cheese.
  • FIG. 1 Percentage of test panel that reports difference between patatin-treated cheese and a reference cheese at the indicated patatin concentration in the milk before coagulation.
  • FIG. 2 Distribution of patatin over curd and whey via a labelling approach.
  • A Milk prior to coagulation.
  • B Milk after coagulation.
  • C Milk containing 2 g/L unlabelled patatin before coagulation.
  • D Milk containing 2 g/L unlabelled patatin after coagulation.
  • E Milk containing 2 g/L Coomassie R-250-labelled patatin before coagulation.
  • F Milk containing 2 g/L Coomassie R-250-labelled patatin after coagulation.
  • G Milk containing 2 g/L Coomassie G-250-labelled patatin before coagulation.
  • H Milk containing 2 g/L Coomassie G-250-labelled patatin after coagulation.
  • FIG. 3 Lipase activity recovered in whey after rennet-coagulation at different patatin doses.
  • FIG. 4 Dose-response relationship between patatin dose and sensory attribute.
  • FIG. 5 Preference of patatin towards the hydrolyis of fatty acid from cheese fat.
  • FIG. 6 Increase in FFA derived volatile cheese favour compounds after 6 weeks ( 6 a ) and after 13 weeks ( 6 b ).
  • FIG. 7 Lipase activity in HMW potato protein powder over two years.
  • patatin is understood to mean the high molecular weight (HMW) fraction of native potato protein isolates, a highly homologous family of glycoproteins having a molecular weight of 30 kDa or more, preferably 35 kDa or more and more preferably of about 43 kDa, and an isoelectric point of less than 5.8, preferably between 4.8 and 5.5, which makes up about 40-50 wt. % of the potato proteins.
  • Patatin is a family of glycoproteins that displays acyl-hydrolase reactivity and accounts for up to 40 wt % of the total soluble protein in potato tubers.
  • PFJ potato fruit juice
  • PFW potato fruit water
  • WO 2008/069650 entails subjecting potato fruit juice to a flocculation by a divalent metal cation at a pH of 7-9, and centrifuging the flocculated potato fruit juice, thereby forming a supernatant. Subsequently, the supernatant is subjected to expanded bed adsorption chromatography operated at a pH of less than 11, and a temperature of 5-35° C. using an adsorbent capable of binding potato protein, thereby adsorbing the native potato protein to the adsorbent. Finally, at least one native potato protein isolate is eluted from the adsorbent with an eluent. This method results among others in isolated native patatin of high purity, with a minimum of denatured protein present and characterised by a stable solubility.
  • the potato fruit juice is pre-treated with a divalent metal cation at a pH of 7-9, preferably 7.0-7.5, to flocculate undesired material, followed by a separation of the flocks by centrifugation.
  • a particularly suitable divalent metal cation is Ca 2+ .
  • This pre-treatment removes undesired material such as negatively charged polymers, pectins, glycoalkaloids, and micro-organisms from the potato fruit juice.
  • the removal of pectins and glycoalkaloids is advantageous, since these compounds adhere to the potato proteins and may cause flocculation, thereby leading to an unstable protein isolate in terms of solubility and other physical properties.
  • the supernatant is subjected to expanded bed adsorption chromatography. It is advantageous to keep the temperature of the starting material below 35 C for a better stability of patatin. Furthermore it is preferred to use a moderately high flow rate, typically in the range of 600-1200 cm/h.
  • the expanded bed adsorption chromatography is operated at a pH of less than 11, preferably at a pH of less than 10.
  • the native potato proteins in the pre-treated potato fruit juice are isolated from the supernatant by binding them onto a suitable adsorbent in the expanded bed adsorption column.
  • Column materials that bind certain amounts of native potato proteins include mixed-mode adsorbentia such as Amersham StreamlineTM Direct CST I (GE Healthcare), Fastline adsorbentia (Upfront Chromatography A/S), macroporous adsorbentia such as AmberliteTM XAD7HP (Röhm & Haas Company) and ion exchange adsorbents.
  • the adsorbent with adsorbed native potato proteins is subsequently eluted with a suitable eluent in order to retrieve the native potato protein isolate, such as patatin.
  • the eluent preferably has a pH in the range of 4-12, more preferably in the range of 5.5-11.0.
  • the proteins can be fractionated to both isoelectric point and molecular weight. This allows separation of for instance patatin and protease inhibitor fractions. Patatin isolates are eluted at a pH of 5.7-8.7, preferably at a pH of 5.8-6.5.
  • Acyl-hydrolase reactivity is generally understood as the ability of a (class of) enzyme(s) to catalyse the hydrolysis of an ester bond by a water molecule to form the constituent carboxylic acid and alcohol. This reaction can sometimes be reversed by suitable adaptation of the reaction conditions, in which case esterification of a carboxylic acid and an alcohol occurs. Reaction conditions that may influence the direction of the reaction include for instance temperature, reactant identity, and/or the amount of water, carboxylic acid and alcohol present.
  • the present invention discloses that patatin has highly selective acyl-hydrolase reactivity, which makes it highly suitable for cheese-making.
  • the hydrolase activity of patatin is directed specifically at acyl groups as found in lipids, in particular mono-, di and triacylglycerides.
  • the hydrolase activity of patatin was known to be strong for monoglycerides. It was, however, also reported that no such activity was found for triglycerides (see for instance Hirschberg et al, Eur. J. Biochem 2001, 268, 5037, Galliard et al., Biochem. J. 1971, 121, 379 or Andrews et al, Biochem J. 1988, 252, 199).
  • triglyceride hydrolase activity for patatin it has surprisingly been found that, despite these reports, there actually is triglyceride hydrolase activity for patatin, and that this activity is very specific for C 4 -C 8 fatty acids.
  • a fatty acid is a class of compounds, characterised by the presence of a 1-positioned carboxylic acid group on a further linear carbon chain.
  • the length of the carbon chain is an important characteristic of a fatty acid, so that a fatty acid having a carbon chain of 10 consecutive linear carbon atoms is called a C 10 fatty acid.
  • the fatty acids known are C 4 -C 36 fatty acids.
  • the carbon chain can be saturated but may also comprise one or more double bonds.
  • Fatty acids are traditionally divided into several groups, using different methods. One method is to divide them according to their degree of saturation. Then, one group of fatty acids is defined as saturated fatty acids, which do not have double bonds between any two carbon atoms in their carbon chain.
  • Unsaturated fatty acids have one or more double bonds in the carbon chain.
  • unsaturated fatty acids there exist mono-unsaturated fatty acids (MUFA), having one double bond in the carbon chain, and polyunsaturated fatty acids (PUFA), having multiple double bonds in the carbon chain.
  • MUFA mono-unsaturated fatty acids
  • PUFA polyunsaturated fatty acids
  • Fatty acids may also be divided according to the length of their carbon chain.
  • SCFA short chain fatty acids
  • HCFA medium-chain fatty acids
  • LCFA long chain fatty acids
  • VLCFA Very long chain fatty acids
  • the carbon chain may be saturated, or mono- or poly unsaturated.
  • Fatty acids are present inside all living organisms, and have several functions. Usually, these functions are exerted by one or more fatty acids incorporated into a larger molecule. Thus, fatty acids can be connected to sugars, amino acids or glycerol-derivatives, and have functions ranging from energy storage to cell structuring, and many more.
  • a lipid for the scope of this invention, is any compound in which a fatty acid is linked through an ester bond to a hydroxyl group of glycerol.
  • Monoacyl-glycerides (MAG or monoglyceride) are esters of glycerol with one fatty acid and two free hydroxyl groups.
  • Diacylglycerides (DAG or diglyceride) are esters of glycerol with two fatty acids and one free hydroxyl group.
  • Triacylglycerides (TAG or triglyceride) are esters of glycerol with three fatty acids.
  • Triacylglycerides are colloquially referred to as “fat”; oil is also a fat but “fat” is generally used to refer to solid or semi-solid triglycerides, whereas “oil” is used for liquid or viscous triglycerides.
  • triglyceride generally comprises three different fatty acids, but the statistical chance of finding a triglyceride having two identical fatty acids is non-negligible.
  • triglycerides with three identical fatty acid units occur naturally.
  • An example is tributyrin (three C 4 fatty acids on a single glycerol backbone), which is known to exist in butter.
  • lipids also include MAGs and DAGs in which a free hydroxyl group of the MAG- or DAG-glycerol is coupled to another group, such as a phosphate group.
  • a molecule in which two fatty acids and a phosphate group are coupled to a single glycerol molecule is referred to as a phospholipid, whereas a molecule in which only one fatty acid is coupled to glycerol, leaving a free hydroxyl-group, is referred to as a lysophospholipid.
  • a phospholipid or a lysophospholipid can have further substitution on the phosphate group.
  • a phospholipid or a lysophospholipid whose phosphate group is further functionalised with choline is referred to as a phosphatidylcholine, and this therefore is a type of phospholipid, and also a type of lipid.
  • lipid colloquially further includes compounds in which one or more fatty acids are coupled through an ester bond to a sugar, such as a monomeric, dimeric or polymeric sugar. In this case, it is called a fatty acid carbohydrate ester or glycolipid.
  • lipids may comprise other esters of fatty acids, such as sterol esters.
  • the term lipid is limited to fatty acid esters of glycerol; other esters of fatty acids such a with sugars or sterols are considered not part of the group of lipids.
  • Lipids are generally separated into two groups: polar lipids, and neutral lipids.
  • the polar lipids dissolve in water to form, for instance, micelles or bilayers, whereas the neutral lipids display very low water solubility.
  • Phospholipids are considered polar lipids, and generally have an octanol-water coefficient (Log P) between 5 and 10.
  • Neutral lipids have low water solubility, and in general have a Log P that is higher than 10.
  • triglycerides includes monoglycerides, diglycerides and triglycerides. Because monoglycerides and diglycerides do essentially not occur naturally, but form by hydrolysis of tryglycerides, the breakdown of neutral lipids always starts with the breakdown of triglycerides. Thus, in a process of hydrolysing neutral lipids, it is advantageous when hydrolysis of triglycerides occurs.
  • Mixture types important in the context of the present invention are:
  • the Tyndall-effect is the elastic scattering of light by particles that are bigger than the wavelength of the light used. It is mostly known from colloidal dispersions and suspensions, and can be used to determine the particle size in such media as is known in the art.
  • a system can be any liquid or semi-liquid environment that will allow for chemical reactions to occur by diffusion of the reactants so that they can “find each other” and interact It can take the shape of a homogeneous solution, a suspension, a water-in-oil or an oil-in-water emulsion, and a colloidal dispersion, either in liquid or in highly viscous, apparent solid form.
  • Solutions are mixtures made by mixing a solute and a solvent.
  • the solute is the substance that dissolves.
  • the solvent is the substance that does the dissolving. Solutions are homogeneous and do not show the Tyndall effect.
  • Colloidal dispersions are mixtures in which two or more immiscible phases are present, so that one phase (a distributed or internal phase) is distributed within another (the continuous phase). Additional immiscible phases may also be present.
  • the internal phase may be liquid, solid or gas, and similarly the continuous phase may be liquid, solid or gas, with the exception that gas-gas dispersions do not exist.
  • Colloidal dispersions appear homogeneous but are actually heterogeneous. However, the one or more internal phases are distributed homogeneously in the continuous phase(s).
  • a characteristic for the scope of this invention is that colloidal dispersions do not settle when left standing undisturbed, as long as no chemical changes in composition occur. Curd and milk are examples of colloidal dispersions. Colloidal dispersions do show the Tyndall effect.
  • Emulsions are heterogeneous mixtures of at least two immiscible liquids. Because a liquid distributed phase is distributed in a liquid continuous phase, emulsions share this feature with colloidal dispersions. For the scope of this invention however, emulsions will settle into their constituent phases when they are left standing undisturbed for long enough time. Thus, an emulsion is distinguished from a colloidal dispersion by the time it remains a stable system in which one phase is distributed homogeneously in another.
  • Suspensions are heterogeneous mixtures of a solid and a liquid in which the solid does not dissolve. Hence they comprise at least two phases in which one phase is distributed homogenously in another, and share this characteristic with a colloidal dispersion. Suspensions, in the terminology of this invention, have larger particles than a solid-liquid colloidal dispersion, and will settle when left standing undisturbed. Suspensions show the Tyndall effect.
  • This invention discloses a method for hydrolysing a fatty acid from a triglyceride that contains at least one C 4 -C 8 fatty acid, comprising subjecting the triglyceride to patatin in the presence of water, wherein the patatin hydrolyses a C 4 -C 8 fatty acid, or catalyses the hydrolysis of a C 4 -C 8 fatty acid.
  • hydrolysis occurs selectively. This is interpreted as that essentially only a C 4 -C 8 fatty acid is hydrolysed from the glycerol backbone.
  • the patatin aids to break the ester bond between the C 4 -C 8 fatty acid and the glycerol backbone.
  • Fatty acids with a shorter or longer carbon chain are essentially not hydrolysed and remain attached to the glycerol backbone in the presence of patatin.
  • C 4 and C 6 fatty acids are hydrolysed, and most preferred is hydrolysis of only C 4 fatty acids, especially in the making of cow's milk cheese, or of only C 6 fatty acids, especially in the making of goat cheese.
  • the position on the glycerol backbone in which the fatty acid is located is of no influence.
  • the outer fatty acid positions (sn(1) and (sn(3)) are hydrolysed somewhat more efficient, but also the fatty acid located at the centre (sn(2)) position can be hydrolysed.
  • the outer positions of the glycerol backbone are hydrolysed with preference over the centre position.
  • the degree of saturation of the fatty acid is not relevant, and both saturated and unsaturated C 4 -C 8 fatty acids can be hydrolysed using the present invention.
  • unsaturated C 4 -C 8 fatty acids are rare, so that preferably, saturated C 4 -C 8 fatty acids are hydrolysed according to the present invention.
  • Hydrolysis according to the present invention thus results in free C 4 -C 8 fatty acids and diglycerides. Subsequently, hydrolysis may continue to form more free fatty acids and monoglycerides and glycerol. Hydrolysis of C 4 -C 8 fatty acids according to the invention may be stopped at any suitable time before hydrolysis is finished.
  • selective hydrolysis of triglycerides is limited to those triglycerides that have only C 4 -C 8 fatty acids on their glycerol backbone.
  • the fatty acids at the outer positions on the glycerol backbone are selectively hydrolysed.
  • the fatty acids for hydrolysis are C 4 and C 6 fatty acids, and most preferred is hydrolysis of only C 4 fatty acids, especially in the making of cow's milk cheese, or of only C 6 fatty acids, especially in the making of goat cheese.
  • log P of triglycerides to be hydrolysed with a method according to the present invention is equal to or lower than 10, preferably lower than 9.2, preferably lower than 6.3. Even more preferably, log P should be in the range of 0.25 to 6.3 and even more preferably in the range of 3.27 to 6.3.
  • Log P for the scope of the present invention, is defined as the partitioning coefficient of the triglyceride between octanol and demineralised water at 25° C., which can routinely be determined by those skilled in the art, for example by using the shake-flask method.
  • Natural fat or natural oil is mainly composed of triglycerides, with a wide range of different fatty acids of varying chain length. Natural fat or natural oil may however contain impurities, such as diglycerides, which form by hydrolysis of triglycerides. The various fatty acids present in natural fats and oils may have a carbon chain of 4 to 28 carbon atoms. The fatty acid profile of a particular type of fat may be determined using any method, such as for instance by a GC-based method according to de Jong and Badings, 1990, J High Resolution Chrom. 13:94-98. The present method is preferentially directed at the hydrolysis of natural fat or natural oil.
  • the patatin used in the present invention is derived from potato Solanum tuberosum .
  • the patatin is isolated from potato juice obtained after starch milling.
  • the potato juice originates from all types of potato cultivars both for industrial starch production or direct human consumption or feed.
  • the patatin is isolated from the potato juice, and preferably it is also purified, such as from other potato proteins and impurities. Further it is preferred for a method according to the present invention to use patatin in native form, i.e. not denatured. Most preferably, native patatin freely dissolved or dispersed in an aqueous phase is used.
  • Hydrolysis of esters according to the present invention can be done in any solvent or without solvent, as long as sufficient water is present to allow the hydrolysis to proceed. It is an important aspect of the present invention that while most lipases function on the interface between hydrophilic and hydrophobic areas, patatin functions best in an aqueous phase. Therefore, the method of the present invention pertains to the hydrolysis of a triglyceride by patatin in the presence of water, preferably in an aqueous phase. Such aqueous phase is preferably comprised in a more hydrophobic phase, such as in an emulsion or colloidal dispersion, to allow sufficient contact between the apolar triglycerides in the hydrophobic phase, and the patatin in the water phase.
  • the aqueous phase may be the continuous phase in a multiphase system.
  • Practical uses that have so far been identified for patatin include an aqueous solution, suspension or emulsion, wherein it is not important whether this is a water-in-oil emulsion or an oil-in-water emulsion.
  • patatin is used in a method to hydrolyse one or more fatty acids from a triglyceride in a colloidal dispersion or an emulsion. In case an emulsion is used, this is preferably a water-in-oil emulsion.
  • Sufficient presence of water is a prerequisite for the invention to allow hydrolysis of a C 4 -C 8 fatty acid off the glycerol backbone of the triglyceride in any system.
  • Sufficient water in this respect means a water content of at least 1 vol. %, preferably at least 5 vol. %, more preferably at least 10 vol. %, more preferably at least 15 vol. %, more preferably at least 20 vol. %, and most preferably at least 25 vol. %, calculated as a percentage of the full system.
  • Temperatures suitable for hydrolysing one or more C 4 -C 8 fatty acids are preferably temperatures at which patatin is active, such as 4-80° C., preferably 10-65° C.
  • temperatures at which patatin is active such as 4-80° C., preferably 10-65° C.
  • a temperature just below denaturation conditions such as for instance 50-65° C.
  • the pH should be so that patatin is active; suitable pH-values at which the hydrolysis of a C 4 -C 8 fatty acid proceeds are between 4.5 and 9, preferably 8.5.
  • the optimum pH to use is between 4.8 and 6.7.
  • the emulsion or colloidal dispersion in which hydrolysis of a C 4 -C 8 fatty acid occurs comprises milk fat.
  • Milk fat is naturally rich in short- and medium chain triglycerides, for which reason patatin is highly suitable for selective hydrolysis of milk. Therefore, the emulsion or colloidal dispersion preferably comprises milk.
  • any type of milk that contains triglycerides comprising C 4 -C 8 fatty acids can be hydrolysed by patatin.
  • any mammal's milk is appropriate, including cow, sheep, goat, donkey, horse, buffalo, yak, reindeer, camel and moose.
  • cow, sheep or goat milk is used in combination with patatin, in particular cow milk.
  • the emulsion or colloidal dispersion of the invention is curd.
  • Curd is a colloidal dispersion obtained from milk, comprising triglycerides, proteins and approximately 30% water.
  • the triglycerides comprise a relatively high abundance of C 4 -C 8 fatty acids, which makes them highly suitable for selective hydrolysis by patatin.
  • Curd takes the shape of a viscous solid-like mass. It is, amongst others, used for the making of cheese.
  • the hydrolysis is carried out in a system which is, or is part of, or is a starting material for the food product.
  • this food product is cheese, most preferably Italian-type cheese, blue cheese or enzyme-modified cheese.
  • hydrolysis is for instance carried out in the milk used for making the cheese and thus form part of a method of preparing this food product, i.e. cheese.
  • patatin in the cheese-making process has considerable advantages over the use of other lipases, such as microbial lipases or rennet.
  • the specificity for C 4 -C 8 fatty acids results in an accelerated cheese production process, and/or in cheese having enhanced flavour. For this reason, curd or milk with added patatin can conveniently be used for cheese-making.
  • patatin When used in a method for cheese-making, it can be added in any or all phases of cheese-making. It can be added to curd directly, but preferably patatin is added to milk before coagulation. It will fractionate mainly with the curd during coagulation.
  • the curd obtained contains approximately 30% water, and should be considered a colloidal dispersion of milk fat, proteins and water.
  • patatin over the use of enzymes of other sources is that patatin has high selectivity for the release of C 4 -C 8 fatty acids from milk fat triglycerides, increasing the speed with which the cheese ripens, and increasing flavour development, thereby enhancing the flavour.
  • patatin has no reactivity towards such substrates. Also, patatin prevents runaway reactions that can cause rancidity due to overly extensive hydrolysis, because it hydrolyses flavour-releasing fatty acids selectively, without hydrolysing other fatty acid esters of glycerol. Finally, in contrast to many microbial lipases, patatin is easily deactivated.
  • Raising the temperature to common pasteurisation temperatures such as for instance between 50 and 80° C., preferably 70-75° C. and more preferably 75° C., essentially inactivates patatin.
  • common pasteurisation temperatures such as for instance between 50 and 80° C., preferably 70-75° C. and more preferably 75° C.
  • essentially inactivates patatin At 75° C., 90% reduction in activity is seen within at most 10 s, whereas at 70° C., 90% reduction in activity is seen within 17 s.
  • a pH-dependency is observed, resulting in longer deactivation times with lower pH, but at pH of 6.7, the activity of patatin is reduced to 90% within 8.2 s at 75° C.
  • Patatin can be used in combination with other enzymes, such as for instance natural rennet or microbial rennet, thereby increasing the ripening speed of cheese and conferring increased flavour development. It can be used in combination with any type of milk coagulation. Therefore, enzymatically curdled cheese, which was coagulated either by rennet or by microbial enzymes, benefits from the addition of patatin. Also acid-curdled cheese, as well as whey cheese, benefits from added patatin because of its specific hydrolysis properties.
  • the milk is cheese milk, which is milk that has been standardised and/or pasteurised for a specific type of cheese. Any milk can be used, as described above.
  • Coagulation induces formation of curd.
  • a watery solution of soluble milk proteins forms, which is called whey.
  • a starter culture comprises at least one enzyme, preferably an enzyme mix, that degrades milk components such as fat and proteins to solidify the cheese, and to induce flavour formation. Addition of patatin, to the milk, the curd or the starter culture, as in the present method, enhances flavour formation and is therefore highly beneficial in the making of cheese.
  • Draining the curd means that at least part of the whey is separated from the curd. This is commonly done by pressing, but other methods are conceivable.
  • the curd is shaped and/or salted, also, in order to obtain an attractive shape and taste, and in order to prevent the growth of microorganisms.
  • a fresh cheese is formed of a fresh cheese.
  • Certain cheeses are customarily eaten as a fresh cheese, but often, a ripening step increases the quality of he cheese.
  • the fresh cheese is allowed to ripen. Ripening the fresh cheese means that the drained curd is left standing for an amount of time that is dependent on the type of cheese.
  • Soft ripened cheeses usually have a minimal ripening time, but other types of cheese may require much more time, such as months or years, to ripen. Ripening for sufficient time results in the final cheese.
  • cheese such as Italian-type cheese, blue cheese and/or enzyme-modified cheese can be prepared following this method, and use of patatin for enhancing the flavour of Italian-type cheese, blue cheese and/or enzyme modified cheese is therefore preferred.
  • Rennet was purchased from SigmaAldrich (R5876). 500 mL aliquots of whole milk were supplemented with patatin at concentrations between 0.1 mg/L and 1.0 g/L and coagulated at 35° C. for 90 minutes by the action of 10 mg/L rennet. A reference coagulated milk was prepared similarly without the addition of patatin (“HMW”). The curd fractions were recovered by straining the coagulate through cheese cloth and pressing. The resulting material was brined by complete submersion in a 90 g/L sodium chloride solution for 1 hour and allowed to ripen for three days at ambient temperature.
  • a nine-person test panel composed of resident laboratory personnel was asked to indicate with certainty whether the scent of each cheese was noticeably different from that of the reference cheese containing no patatin. After three days, the cheeses containing 1 mg/L or more patatin had a noticeably different scent from the reference cheese (for graphic results, see FIG. 1 ).
  • Solanic HMW potato protein isolate was used as an essentially pure patatin preparation.
  • Coomassie Brilliant Blue was from Merck (G-250 1.15444, R-250 1.12553).
  • PD10 gel filtration columns were from GE Healthcare. Rennet was purchased from SigmaAldrich (R5876).
  • patatin A 4.0% (m:m) solution of patatin was prepared in demineralised water and incubated with equimolar amounts of either Coomassie Brilliant Blue R-250 or Coomassie Brilliant Blue G-250 and incubated at ambient temperature under constant stirring for 30 minutes. After incubation any unbound dye was removed from the protein by gel filtration on PD 10 disposable gel filtration columns. Dye-labelled patatin solutions were stored at ⁇ 28° C. until use.
  • Photographs of the curd and whey fractions were taken to allow the distribution of dye to be inspected optically ( FIG. 2 ).
  • Spectrophotometric quantification of the amount of blue dye in the whey was unsuccessful because of residual turbidity that was insufficiently removed by neither centrifugation nor microfiltration.
  • Known lipase substrates were purchased from SigmaAldrich (4-nitrophenylcaprylate, 21742). 5 mL aliquots of milk were supplemented with different doses of patatin between 50 mg/L and 500 mg/L. Total volume was kept constant by the addition of demi-water if required. The resulting mixtures as well as untreated milk as a control were coagulated by the addition of rennet at 10 mg/L and incubating for 90 minutes at 35° C. The resulting material was separated into curd and whey by centrifugation at 9000 g for 10 minutes. The whey was then transferred into microvials and centrifuged again at 15000 g for 10 minutes to obtain a slightly opaque solution.
  • Residual lipase activity in whey may be undesired because it can lead to degradation of the remaining milk fat. This would result in the presence of volatile, odorous free fatty acids in the whey, modifying the taste with time. In addition, products prepared from the whey would contain lipolytic activity, potentially limiting their application.
  • Patatin Solanic 206P HMW potato protein was dissolved to a concentration of 1 g/L in buffer solutions of pH 5, 6 and 7, and in freshly prepared whey of pH 6.7. Kinetic degradation models of the lipase activity in these solutions were constructed by measuring residual activity upon thermal exposure in a stopped-flow system.
  • Whey was prepared from whole milk exposed to 10 mg/L rennet (SigmaAldrich R5876) at 30° C. for 90 minutes and removing the curd by filtration through cheese cloth. Patatin solutions were exposed to temperatures between 50° and 80° C. at exposure times ranging between 4 ms up to 10 s. Lipase activity was determined by measuring the increase in absorbance at 340 nm of the patatin solution acting on 4-methylumbelliferyl acetate (Alfa Aesar A12147) in 30 mM phosphate buffer of pH 8.0 for 3 minutes. The data were fitted according to Arrhenius kinetics essentially according to the method of Anton and Barret (Anton, G. E. and Barrot D. M., 2002 JAFC, 50, p. 4119-25 “Inactivation of Quality-Related Enzymes in Carrots and Potatoes”).
  • whey typically undergoes a pasteurization step at 75° C. At this temperature, the data show that residual lipase activity is inactivated in a matter of seconds, specifically within at most 10 seconds.
  • One vat of curd (200 L) was prepared as in usual cheese-making, using thermised bactofugated standardised and pasteurised cheese milk.
  • the processing protocol for Gouda-type cheese was followed. Rennet (Kalase, CSK Food Enrichment, Leeuwarden, The Netherlands) and starter (Bos mesophilic starter, CSK Food Enrichment, Leeuwarden, The Netherlands) were added to the vat. After washing the curd, it was divided into 10 portions with different doses of patatin (Solanic 206P) mixed thoroughly. These doses ranged between 30 and 0.1 mg patatin/L cheese milk.
  • the curds were pre-pressed, divided into 4 equal parts and each placed in a cheese vat. The resulting cheeses ( ⁇ 350 g each) were pressed, brined, vacuum-packed and ripened at 13° C. for 6 or 13 weeks.
  • Fatty acid-derived volatiles such as ketones, aldehydes and esters increased in a dose-dependant manner with the amount of patatin added ( FIG. 6 ).
  • HMW potato protein powder samples covering two years of production time were dissolved at 2% concentration in 100 mM pH 8.0 phosphate buffer. Solids were removed by centrifugation and the supernatants were analysed for lipase activity on 4 mM of paranitrophenyl caprylate (SigmaAldrich 21742) in the presence of 3 mg/mL sodium dodecyl sulphate by spectrometric measurement of the absorbance at 405 nm at 30° C. Activities were then calculated using a molar extinction coefficient of 16888 and expressed as units of lipase activity/mg powder. All analyses were performed in a single experimental series.
  • patatin has no activity towards triglycerides.
  • Solanics patatin products show low but clearly present activity towards short- and medium chain triglycerides having C 4 -C 8 fatty acids, and in some cases also for C 10 fatty acids.
  • An activity above 0.025 mmol/min/g is considered significant for food production processes, among which cheese-making.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Fats And Perfumes (AREA)
  • Seasonings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Fruits And Vegetables (AREA)
  • Liquid Carbonaceous Fuels (AREA)
US14/411,536 2012-07-04 2013-07-03 Methods using patatin Abandoned US20150189896A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12174894.1 2012-07-04
EP12174894 2012-07-04
PCT/NL2013/050488 WO2014007621A1 (en) 2012-07-04 2013-07-03 Methods using patatin

Publications (1)

Publication Number Publication Date
US20150189896A1 true US20150189896A1 (en) 2015-07-09

Family

ID=48833028

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/411,536 Abandoned US20150189896A1 (en) 2012-07-04 2013-07-03 Methods using patatin
US14/411,954 Active 2033-09-06 US10034485B2 (en) 2012-07-04 2013-07-03 Lipase in short-chain esterification of fatty acids

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/411,954 Active 2033-09-06 US10034485B2 (en) 2012-07-04 2013-07-03 Lipase in short-chain esterification of fatty acids

Country Status (11)

Country Link
US (2) US20150189896A1 (ja)
EP (2) EP2870252B1 (ja)
JP (2) JP6230601B2 (ja)
CN (2) CN104428419A (ja)
BR (2) BR112014032741B1 (ja)
CA (2) CA2873366C (ja)
DK (1) DK2870252T3 (ja)
EA (2) EA025269B9 (ja)
MX (2) MX357703B (ja)
PL (1) PL2870252T3 (ja)
WO (2) WO2014007621A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170360737A1 (en) * 2014-10-30 2017-12-21 Fuji Oil Holdings Inc. Long-chain polyunsaturated fatty-acid-containing fat and food containing same

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3371293B1 (en) * 2015-11-06 2019-08-07 Coöperatie Avebe U.A. Fermentation
EP3213638A1 (en) * 2016-03-01 2017-09-06 Coöperatie Avebe U.A. Vegan cheese analogue
US20180289036A1 (en) * 2017-03-31 2018-10-11 J.R. Simplot Company Potato protein powders
EP3578630B1 (en) 2018-06-04 2020-12-02 The Procter & Gamble Company Liquid detergent composition
EP3944769A1 (en) 2020-07-30 2022-02-02 Coöperatie Koninklijke Avebe U.A. Patatin as binder in meat substitutes
AU2022229626A1 (en) * 2021-03-02 2023-09-21 Coöperatie Koninklijke Avebe U.A. Patatin-emulsified binder
EP4376623A1 (en) 2021-07-29 2024-06-05 Coöperatie Koninklijke Avebe U.A. Patatin as binder in food products other than meat substitutes
WO2023080785A1 (en) 2021-11-03 2023-05-11 Coöperatie Koninklijke Avebe U.A. Patatin inhibition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110312043A1 (en) * 2010-06-18 2011-12-22 Butamax(Tm) Advanced Biofuels Llc Extraction solvents derived from oil for alcohol removal in extractive fermentation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6398707B1 (en) 2001-05-31 2002-06-04 Wen-Teng Wu Method of preparing lower alkyl fatty acids esters and in particular biodiesel
US7943360B2 (en) * 2002-04-19 2011-05-17 Verenium Corporation Phospholipases, nucleic acids encoding them and methods for making and using them
US7226771B2 (en) * 2002-04-19 2007-06-05 Diversa Corporation Phospholipases, nucleic acids encoding them and methods for making and using them
EP1601332A4 (en) * 2003-03-07 2012-05-02 Verenium Corp HYDROLASES, NUCLEIC ACIDS ENCODING THEM, AND METHODS OF MAKING AND USING SAME
EP1920662A1 (en) 2006-11-10 2008-05-14 Coöperatie Avebe U.A. Native potato protein isolates
CA2669212C (en) * 2006-11-10 2014-08-19 Marco Luigi Federico Giuseppin Glycoalkaloid removal
ES2429492T3 (es) * 2008-02-29 2013-11-15 Dsm Ip Assets B.V. Lipasas con alta especificidad hacia ácidos grasos de cadena corta y usos de las mismas
WO2010102976A1 (en) * 2009-03-10 2010-09-16 Dsm Ip Assets B.V. Pregastric esterase and derivatives thereof
JP2011148874A (ja) * 2010-01-20 2011-08-04 Daiki Axis:Kk 脂肪酸アルキルエステルの製造方法とその製造装置
JP5756972B2 (ja) * 2010-02-24 2015-07-29 国立研究開発法人産業技術総合研究所 バイオディーゼル燃料の製造方法及びバイオディーゼル燃料組成物
US20110211679A1 (en) * 2010-02-26 2011-09-01 Vladimir Mezhibovsky Voice Response Processing
CN103476936A (zh) 2010-06-18 2013-12-25 布特马斯先进生物燃料有限责任公司 醇发酵过程中醇酯的生产和原位产物移出
JP5793288B2 (ja) * 2010-09-30 2015-10-14 綱 秀 典 金 バイオ石油燃料製造方法と、それに使用する触媒および製造システム

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110312043A1 (en) * 2010-06-18 2011-12-22 Butamax(Tm) Advanced Biofuels Llc Extraction solvents derived from oil for alcohol removal in extractive fermentation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Hoang JHB in Eur J. Biochem. 268: 5037-5044, 2001. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170360737A1 (en) * 2014-10-30 2017-12-21 Fuji Oil Holdings Inc. Long-chain polyunsaturated fatty-acid-containing fat and food containing same

Also Published As

Publication number Publication date
MX357703B (es) 2018-07-20
JP2015521845A (ja) 2015-08-03
CA2873378A1 (en) 2014-01-09
JP6231091B2 (ja) 2017-11-15
WO2014007622A1 (en) 2014-01-09
EA025269B9 (ru) 2017-03-31
DK2870252T3 (da) 2020-03-16
JP6230601B2 (ja) 2017-11-15
JP2015527060A (ja) 2015-09-17
MX362234B (es) 2019-01-09
CN104428420A (zh) 2015-03-18
US20150140618A1 (en) 2015-05-21
EP2870252A1 (en) 2015-05-13
EA025269B1 (ru) 2016-12-30
PL2870252T3 (pl) 2020-07-13
CN104428420B (zh) 2018-06-01
CN104428419A (zh) 2015-03-18
BR112014032741A2 (pt) 2017-06-27
EP2870252B1 (en) 2020-01-22
EA201491986A1 (ru) 2015-05-29
BR112014032741B1 (pt) 2022-01-25
US10034485B2 (en) 2018-07-31
MX2014014876A (es) 2015-03-09
MX2014014866A (es) 2015-04-08
CA2873378C (en) 2020-01-14
BR112014032171A2 (pt) 2017-06-27
EA201491987A1 (ru) 2015-06-30
EA027459B1 (ru) 2017-07-31
CA2873366A1 (en) 2014-01-09
EP2870253A1 (en) 2015-05-13
WO2014007621A1 (en) 2014-01-09
CA2873366C (en) 2021-06-15

Similar Documents

Publication Publication Date Title
EP2870252B1 (en) Methods using patatin
JP6942606B2 (ja) 摂食可能品のための方法および組成物
KR100450065B1 (ko) 무수성 동물성 지방에서 유리지방산과 콜레스테롤을 줄이는 방법
Kailasapathy et al. Application of encapsulated enzymes to accelerate cheese ripening
Deeth et al. Lipolytic enzymes and hydrolytic rancidity
JP7015236B2 (ja) 風味改良材
BUSTAMANTE et al. Coagulating and lipolytic activities of artisanal lamb rennet pastes
CN104705418B (zh) 一种双酶法增香的奶油以及乳脂肪制品及其制备方法
Ye et al. Structural changes to milk protein products during gastrointestinal digestion
Abeijon Mukdsi et al. Contribution of lactic acid bacteria esterases to the release of fatty acids in miniature ewe’s milk cheese models
Calvo et al. Purification and characterization of a pregastric esterase from a hygienized kid rennet paste
JP4273741B2 (ja) 魚油臭のマスキング方法
Oliveira et al. Composition, Fractionation, Techno-Functional Properties and Applications of Milk Fat Globule Membrane–Derived Material
Torres et al. The influence of milk-clotting enzymes on the lipid composition and organoleptic properties of semi-matured cheeses
EP3434108B1 (de) Lipasen aus basidiomyceten für den einsatz in der käserei
Marangoni Free fatty acids in milk: Origin and effects on milk quality
Prapun Study on extraction, Quality and application of virgin coconut oil
Ghavam Utilization of camel chymosin in the production of reduced fat ultrafiltrated white cheese and its effect on cheese quality
Liaw Flavor and flavor chemistry of liquid mozzarella and cheddar cheese whey
HILMA FATTY ACID CONCEN TRATION OF FISH OIL COMPARED WITH FRESH SPUN PASTE CHEESE ENRICHED IN ESSENTIAL FATTY ACIDS
Ismail Production of fatty acid alcohol esters by esterase activity from Pseudomonas fragi
Udhyog Cholesterol removal in goat milk cheese and its chemical, textural and sensory evaluation during storage
Asaduzzaman Recovery and Characterization of Bioactive Compounds from Mackerel (Scomber japonicus) using Sub-and Supercritical Fluids
Manion Compositional and functional properties of fractions rich in milk fat globule membrane material
USGAME-FAGUA et al. The influence of milk-clotting enzymes on the lipid composition and organoleptic properties of semi-matured cheeses* Influencia de las enzimas coagulantes

Legal Events

Date Code Title Description
AS Assignment

Owner name: COOEPERATIE AVEBE U.A., NETHERLANDS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SPELBRINK, ROBIN ERIC JACOBUS;GIUSEPPIN, MARCO LUIGI FEDERICO;EGMOND, MAARTEN ROBERT;SIGNING DATES FROM 20150205 TO 20150217;REEL/FRAME:035091/0832

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION